| NAME |
GANAXOLONE 50MG/ML SUSP,ORAL |
| VA GENERIC NAME |
GANAXOLONE |
| DOSAGE FORM |
SUSP,ORAL |
| FDA MED GUIDE |
Ganaxolone_(Ztalmy)_(Nov_2022).pdf |
| HAZARDOUS TO DISPOSE |
NO |
| ACTIVE INGREDIENTS |
|
| CS FEDERAL SCHEDULE |
Schedule V |
| STRENGTH |
50 |
| SINGLE/MULTI SOURCE PRODUCT |
Single source |
| UNITS |
MG/ML |
| NATIONAL FORMULARY NAME |
GANAXOLONE SUSP,ORAL |
| CREATE DEFAULT POSSIBLE DOSAGE |
YES |
| CODING SYSTEM |
|
| COPAY TIER |
-
- COPAY TIER LEVEL: 3
- COPAY EFFECTIVE DATE: 2022-06-23 00:00:00
|
| PGX ELIGIBLE |
NO |
| PGX SUPPRESSED |
NO |
| VA PRINT NAME |
GANAXOLONE 50MG/ML ORAL SUSP |
| VA PRODUCT IDENTIFIER |
G0508 |
| TRANSMIT TO CMOP |
NO |
| VA DISPENSE UNIT |
ML |
| MASTER ENTRY FOR VUID |
YES |
| VUID |
4041532 |
| EFFECTIVE DATE/TIME |
-
- 2022-06-23 00:00:00
- STATUS: ACTIVE
|
